Medicine, Gastroenterology Division

Grants

Grants per year 2001 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2030

• 66 Active
• 237 Finished

Grants per year

Search results

• Active

  Prot #GA45331: A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Treat-Through Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy with RO7790121 in Patients with Moderately to Severely Active Crohn’s Disease

  Dulai, P. S. (PD/PI)

  ICON Clinical Research, LLC, Genentech, Inc

  3/21/25 → 12/1/30

  Project: Research project

• Prot #TAK01796: Characterization of Early Response to Vedolizumab and IL-23 Antagonists in Participants with Crohn’s Disease Using Patient-Reported Outcome Measures (VOICE): A Prospective Observational Study

  Dulai, P. S. (PD/PI)

  Robarts Clinical Trials Inc, Takeda Development Center Americas, Inc.

  3/20/25 → 3/20/28

  Project: Research project

• Pandolfino Chart Styring

  Pandolfino, J. E. (PD/PI), Carlson, D. A. (Co-Investigator), Hungness, E. (Co-Investigator), Kou, W. (Co-Investigator) & Schauer, J. M. (Co-Investigator)

  National Institute of Diabetes and Digestive and Kidney Diseases

  1/20/25 → 11/30/28

  Project: Research project

• Prot #ABX464-107: A Randomized, Double-Blind, Multicenter Phase III Study to Evaluate the Long-Term Efficacy and Safety of ABX464 25 mg or 50 mg Once Daily as a Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis – ABTEC

  Hanauer, S. B. (PD/PI)

  Quintiles, Inc., Abivax

  12/18/24 → 12/18/27

  Project: Research project

• Prot #ABX464-105: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects with Moderately to Severely Active Ulcerative Colitis (ABTECT-1)

  Hanauer, S. B. (PD/PI)

  Quintiles, Inc., Abivax

  11/19/24 → 11/19/27

  Project: Research project

• Prot #M23-703: A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

  Boumitri, C. (PD/PI)

  AbbVie Inc.

  10/2/24 → 10/2/25

  Project: Research project

• Evaluating equity in antibiotic stewardship and disparities in appropriateness of antibiotic treatment

  Evans, C. T. (PD/PI), Balbale, S. N. (Co-Investigator), Dhanani, M. (Co-Investigator) & Sutton, S. H. (Co-Investigator)

  Agency for Healthcare Research and Quality

  9/30/24 → 7/31/29

  Project: Research project

• Prot #LPS17558: A Phase 4, Randomized, Multicenter, Double-Blind, Parallel-Group, 24 Weeks, Placebo-Controlled Study Followed by 104 Weeks Open-Label to Assess Dupilumab Efficacy on Esophageal Function and Remodeling in Adult Participants with Eosinophili

  Gonsalves, N. P. (PD/PI)

  ICON Clinical Research, LLC, Sanofi US Services Inc.

  9/26/24 → 9/26/27

  Project: Research project

• Project 2

  Avella Patino, D. M. (Co-Investigator), Pandolfino, J. E. (Co-Investigator) & Perlman, H. R. (Other)

  National Heart, Lung, and Blood Institute

  9/17/24 → 7/31/29

  Project: Research project

• VA IPA for Richard Green

  Pandolfino, J. E. (PD/PI) & Green, R. (Co-PD/PI)

  Southern Arizona VA Health Care System

  9/16/24 → 9/15/25

  Project: Research project

• (RFA) STING suppresses colitis through regulation of intestinal barrier function

  Yang, W. (PD/PI) & Cong, Y. (Other)

  Crohn's and Colitis Foundation of America

  9/1/24 → 8/31/27

  Project: Research project

• A Pilot Assessment of Sleep and Circadian Rest-Activity Rhythms in IBD Patients

  Summa, K. C. (PD/PI)

  Northwestern Memorial Hospital

  9/1/24 → 8/31/26

  Project: Research project

• Evolution of the Chicago Classification: Bridging Physiology and Mechanics

  Carlson, D. A. (PD/PI), Pandolfino, J. E. (PD/PI), Kou, W. (Co-Investigator), Patankar, N. A. (Co-Investigator) & Schauer, J. M. (Co-Investigator)

  National Institute of Diabetes and Digestive and Kidney Diseases

  8/15/24 → 6/30/28

  Project: Research project

• Prot #R668-EGE-2213: A Phase 2/3, Randomized, 3-part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients with Eosinophilic Gastritis with or without Eosinophilic Duodenitis

  Gonsalves, N. P. (PD/PI)

  ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

  8/2/24 → 8/2/27

  Project: Research project

• Investigating the Molecular Mechanisms of Basal Cell Hyperplasia Persistence After Treatment in Eosinophilic Esophagitis

  Tetreault, M.-P. (PD/PI), Carlson, D. A. (Other) & Gonsalves, N. P. (Other)

  American Partnership for Eosinophilic Disorders

  8/1/24 → 7/31/26

  Project: Research project

• Impact of Computer Aided Detection on Trainee Polyp Miss Rate Using A Tandem Colonoscopy Design

  Keswani, R. N. (PD/PI)

  Medtronic, Inc.

  5/23/24 → 11/23/26

  Project: Research project

• STING signaling in T cells regulation of intestinal homeostasis and inflammatorybowel diseases

  Cong, Y. (PD/PI), Cong, Y. (PD/PI), Yang, W. (Other), Yang, W. (Other), Yao, S. (Other), Yao, S. (Other), Yu, T. (Other) & Yu, T. (Other)

  National Institute of Diabetes and Digestive and Kidney Diseases

  5/1/24 → 4/30/26

  Project: Research project

• The Neu-Lung Consortium: Neutrophilic Mechanisms of Inflammation, Injury, and Repair in Lung and Airways Diseases

  Misharin, A. (Co-PD/PI), Abdala-Valencia, H. (Co-Investigator), Dulai, P. S. (Other) & Robinson, A. (Other)

  National Institute of Allergy and Infectious Diseases

  4/1/24 → 3/31/29

  Project: Research project

• Diabetes RElated to Acute Pancreatitis and its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics (DREAM-ON)

  Keswani, R. N. (PD/PI)

  Pennsylvania State University, National Institute of Diabetes and Digestive and Kidney Diseases

  4/1/24 → 3/31/27

  Project: Research project

• Colonoscopy versus Stool-based Testing for Older Adults with a History of Colon Polyps (COOP)

  Keswani, R. N. (PD/PI)

  Dartmouth-Hitchcock Medical Center, Patient-Centered Outcomes Research Institute

  4/1/24 → 9/30/29

  Project: Research project

• Prot #12.06.2022: Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples for the Non-Endoscopic Detection of Barrett’s Esophagus with and without Dysplasia

  Komanduri, S. (PD/PI)

  Mayo Clinic, EXACT Sciences Corporation

  3/28/24 → 3/28/27

  Project: Research project

• Prot #Vedolizumab-4052: Re-define the IBD disease burden status

  Dulai, P. S. (PD/PI) & Mao, C. (Co-Investigator)

  Takeda Pharmaceuticals U.S.A., Inc.

  3/11/24 → 3/11/27

  Project: Research project

• Gut microbiota metabolite sensing licenses IEC to cross talk with T cells to inhibit intestinal inflammation

  Cong, Y. (PD/PI), Yang, W. (Other), Yao, S. (Other) & Yu, T. (Other)

  National Institute of Diabetes and Digestive and Kidney Diseases

  3/1/24 → 1/31/27

  Project: Research project

• CEGIR - OATFEED

  Gonsalves, N. P. (PD/PI), Gonsalves, N. P. (PD/PI), Hirano, I. (Co-Investigator) & Hirano, I. (Co-Investigator)

  Cincinnati Children's Hospital Medical Center

  1/22/24 → 8/31/25

  Project: Research project

• Prot #1425-0003: A Phase IIa, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BI 706321 Orally Administered for 12 Weeks in Patients with Crohn`s Disease (CD) Receiving Ustekinu

  Hanauer, S. B. (PD/PI)

  Quintiles, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.

  1/17/24 → 1/17/27

  Project: Research project